Catalyst Biosciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | -$0.04 | -$0.04 | -$0.04 |
| Q2 2024 | 0 | $1.34 | $1.34 | $1.34 |
| Q3 2024 | 0 | $1.54 | $1.54 | $1.54 |
Catalyst Biosciences, Inc. Earnings Date And Information
Catalyst Biosciences, Inc. last posted its earnings results on Monday, August 14th, 2023. The company reported $-0.07 earnings per share for the quarter, missing analysts' consensus estimates of $-0.07 by $0. The company had revenue of 0 for the quarter and had revenue of 794,000 for the year. Catalyst Biosciences, Inc. has generated $0 earnings per share over the last year ($-0.26 diluted earnings per share) and currently has a price-to-earnings ratio of -4.8. Catalyst Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 25th, 2023 based on prior year's report dates.
Catalyst Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/26/2023 | Q3 2023 | -$0.04 | $0 | $0 | ||
| 08/14/2023 | Q2 2023 | -$0.07 | -$0.07 | 0 | $0 | |
| 05/15/2023 | Q1 2023 | -$0.07 | $0.01 | 0.08 | $0 | |
| 03/30/2023 | Q4 2022 | -$0.10 | -$1.28 | -1.18 | $-794,000 | |
| 11/14/2022 | Q3 2022 | -$0.10 | -$0.15 | -0.05 | $215,049 | $0 |
| 08/15/2022 | Q2 2022 | $1.64 | $417,449 | $0 | ||
| 05/09/2022 | Q1 2022 | -$0.56 | -$0.46 | 0.1 | $794,000 | |
| 03/31/2022 | Q4 2021 | -$0.54 | -$0.65 | -0.11 | $2.44 M | |
| 11/12/2021 | Q3 2021 | -$0.66 | -$0.80 | -0.14 | $170,000 | $2.30 M |
| 08/05/2021 | Q2 2021 | -$0.68 | -$0.64 | 0.04 | $330,000 | $1.13 M |
| 05/06/2021 | Q1 2021 | -$0.77 | -$0.79 | -0.02 | $1.47 M | |
| 03/04/2021 | Q4 2020 | -$0.89 | -$0.85 | 0.04 | $2.03 M | |
| 11/05/2020 | Q3 2020 | -$0.95 | -$0.73 | 0.22 | $990,863 | $893,000 |
| 08/06/2020 | Q2 2020 | -$1.05 | -$0.96 | 0.09 | $1.49 M | $1.66 M |
| 05/11/2020 | Q1 2020 | -$0.36 | -$0.28 | 0.08 | $16.37 M | |
| 02/20/2020 | Q4 2019 | -$1.23 | -$1.13 | 0.1 | $0 | |
| 11/07/2019 | Q3 2019 | -$1.19 | -$1.06 | 0.13 | $0 | |
| 08/01/2019 | Q2 2019 | -$1.20 | -$1.15 | 0.05 | $0 | |
| 05/02/2019 | Q1 2019 | -$0.87 | -$1.26 | -0.39 | $0 | |
| 03/08/2019 | Q4 2018 | -$0.91 | $-6,000 |
Catalyst Biosciences, Inc. Earnings: Frequently Asked Questions
-
When is Catalyst Biosciences, Inc.'s earnings date?
Catalyst Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 25th, 2023 based off last year's report dates.
-
How can I listen to Catalyst Biosciences, Inc.'s earnings conference call?
The conference call for Catalyst Biosciences, Inc.'s latest earnings report can be listened to online.
-
How can I read Catalyst Biosciences, Inc.'s conference call transcript?
The conference call transcript for Catalyst Biosciences, Inc.'s latest earnings report can be read online.
-
How much revenue does Catalyst Biosciences, Inc. generate each year?
Catalyst Biosciences, Inc. (:CBIO) has a recorded annual revenue of $794,000.
-
How much profit does Catalyst Biosciences, Inc. generate each year?
Catalyst Biosciences, Inc. (:CBIO) has a recorded net income of $794,000. Catalyst Biosciences, Inc. has generated $-0.26 earnings per share over the last four quarters.
-
What is Catalyst Biosciences, Inc.'s price-to-earnings ratio?
Catalyst Biosciences, Inc. (:CBIO) has a price-to-earnings ratio of -4.8 and price/earnings-to-growth ratio is -0.65.
